BeStock  
Stocks › Medical Devices › CTKB

Cytek Biosciences CTKB

US equityMarket cap rank #3306Medical Devices
$6.12 −$0.20 (-3.16%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.12 0.00%
Open$6.31
Prev close$6.32
Day range$5.99 – $6.39
Volume1.77M
Market cap$800.40M
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±10.5%last 16 reports
Closed higher6 of 1638% of the time
Best reaction+36.0%
Worst reaction-24.0%

Stock move on the day after each report

-11.9%2023/Q4-1.1%2024/Q1-9.4%2024/Q2+36.0%2024/Q3-6.7%2024/Q4-22.8%2025/Q1+5.7%2025/Q2+13.2%2025/Q3+1.8%2025/Q4-6.3%2026/Q1-0.5%2026/Q2-8.2%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q34 Nov 2026After Market±84.4%-8.16%Within range
2026/Q25 Aug 2026After Market–-0.48%–
2026/Q17 May 2026After Market–-6.30%–
2025/Q426 Feb 2026After Market–+1.82%–
2025/Q35 Nov 2025After Market–+13.22%–
2025/Q26 Aug 2025After Market–+5.66%–
2025/Q18 May 2025After Market–-22.82%–
2024/Q427 Feb 2025After Market–-6.65%–
2024/Q35 Nov 2024After Market±38.2%+36.03%Within range
2024/Q26 Aug 2024After Market±45.9%-9.43%Within range
2024/Q18 May 2024After Market±23.1%-1.12%Within range
2023/Q428 Feb 2024After Market±21.7%-11.90%Within range
2023/Q37 Nov 2023After Market–+12.36%–
2023/Q28 Aug 2023After Market±16.3%+0.78%Within range
2023/Q19 May 2023After Market±15.7%-24.04%Bigger than priced
2022/Q428 Feb 2023After Market–-7.86%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Product$37.16M 69.8%
  • Service$16.07M 30.2%

Latest reported quarter: Q3, ended Sep 2026

Revenue$53.23M+1.8% YoY
Operating profit-$8.42M+8.4% YoY
Net profit-$6.10M-11.3% YoY
Diluted EPS-$0.05-25.0% YoY
Free cash flow-$6.00M-31.8% YoY
Operating cash flow-$4.45M

Revenue, last 8 quarters

$57.5MDec '24$41.5MMar '25$45.6MJun '25$52.3MSep '25$62.1MDec '25$44.1MMar '26$48.1MJun '26$53.2MSep '26

Net profit, last 8 quarters

$9.6MDec '24$-11.4MMar '25$-5.6MJun '25$-5.5MSep '25$-44.1MDec '25$-18.9MMar '26$-12.2MJun '26$-6.1MSep '26

Profitability & balance sheet

Gross margin54.7%
Operating margin-21.1%
Net margin-39.1%
Return on equity-23.2%
Return on assets-17.3%
Return on invested capital-22.2%
Current ratio4.46
Liabilities / assets28.0%
Cash & investments$255.90M
Total debt$21.23M
Net cash (debt)$234.67M

Discussion

No comments yet — be the first to weigh in on CTKB.

Sign in to join the discussion.

Scroll to Top